Literature DB >> 10642049

The role of technical, biological, and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. VII. Seasonal influences on anticonvulsant drug actions in mouse models of generalized seizures.

W Löscher1, M Fiedler.   

Abstract

Seasonal or circannual rhythms have been reported in various physiologic, biochemical, pharmacological, and toxicological studies in mice and rats despite laboratory conditions with standardized and controlled light cycle, temperature, humidity, and food. This may either be explained by the existence of innate, free-running circannual rhythms or by the existence of seasonally varying environmental factors ('zeitgeber') which are detected by the animals despite controlled laboratory conditions. In the present study, it was evaluated whether circannual rhythms affect the anticonvulsant activity of phenobarbital, carbamazepine, or valproate in two mouse models of generalized seizures, i.e. the threshold for generalized tonic seizures in the maximal electroshock seizure (MES) test and the threshold for different types of generalized seizures induced by the chemical convulsant pentylenetetrazol (PTZ). A study protocol was used with data sampling in separate groups of mice per month (using each group only once) over a period of 13 months beginning and ending in late summer (September), so that data collected in the other seasons could be compared with summer values of 2 subsequent years. With all three anticonvulsants, marked seasonal variation was observed in both seizure models with lowest anticonvulsant efficacy and potency in March and April, i.e. in late winter and early spring. The most marked loss of anticonvulsant activity in this period of the year was observed with valproate. Analysis of drug levels in plasma and brain indicated that the seasonal variation in phenobarbital's and carbamazepine's anticonvulsant effect was predominantly due to alterations in drug metabolism leading to reduced brain levels in March and April, while the seasonal rhythm in valproate's activity appeared to be mainly related to altered pharmacodynamic activity. These findings indicate that the time of the year is an important variable in the experimental evaluation of anticonvulsant drugs. Furthermore, the present data add to the accumulating evidence that endogenous circannual rhythms should be considered during animal experiments under controlled laboratory conditions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10642049     DOI: 10.1016/s0920-1211(99)00095-9

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  6 in total

1.  Impairment in behavioral sedation in rats during periods of elevated global geomagnetic activity.

Authors:  Neil M Fournier
Journal:  Int J Biometeorol       Date:  2019-06-17       Impact factor: 3.787

2.  Effect of Various Antiepileptic Drugs in Zebrafish PTZ-Seizure Model.

Authors:  P Gupta; S B Khobragade; V M Shingatgeri
Journal:  Indian J Pharm Sci       Date:  2014-03       Impact factor: 0.975

3.  Influence of methadone on the anticonvulsant efficacy of valproate sodium gabapentin against maximal electroshock seizure in mice by regulation of brain MDA TNF-α.

Authors:  Ali Moradi Jafari; Majid Hassanpourezatti
Journal:  Front Neurol       Date:  2022-08-23       Impact factor: 4.086

4.  Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo.

Authors:  Michał Abram; Marcin Jakubiec; Katelyn Reeb; Mary Hongying Cheng; Robin Gedschold; Anna Rapacz; Szczepan Mogilski; Katarzyna Socała; Dorota Nieoczym; Małgorzata Szafarz; Gniewomir Latacz; Bartłomiej Szulczyk; Justyna Kalinowska-Tłuścik; Kinga Gawel; Camila V Esguerra; Elżbieta Wyska; Christa E Müller; Ivet Bahar; Andréia C K Fontana; Piotr Wlaź; Rafał M Kamiński; Krzysztof Kamiński
Journal:  J Med Chem       Date:  2022-08-19       Impact factor: 8.039

5.  The Role of BK Channels in Antiseizure Action of the CB1 Receptor Agonist ACEA in Maximal Electroshock and Pentylenetetrazole Models of Seizure in Mice.

Authors:  Sina Asaadi; Mohammad Jahanbakhshi; Mahmoud Lotfinia; Nima Naderi
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

Review 6.  Climate change and epilepsy: Insights from clinical and basic science studies.

Authors:  Medine I Gulcebi; Emanuele Bartolini; Omay Lee; Christos Panagiotis Lisgaras; Filiz Onat; Janet Mifsud; Pasquale Striano; Annamaria Vezzani; Michael S Hildebrand; Diego Jimenez-Jimenez; Larry Junck; David Lewis-Smith; Ingrid E Scheffer; Roland D Thijs; Sameer M Zuberi; Stephen Blenkinsop; Hayley J Fowler; Aideen Foley; Sanjay M Sisodiya
Journal:  Epilepsy Behav       Date:  2021-02-10       Impact factor: 3.337

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.